Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0000950170-24-063590
Filing Date
2024-05-22
Accepted
2024-05-22 17:12:36
Documents
5
Effectiveness Date
2024-05-22

Document Format Files

Seq Description Document Type Size
1 S-8 POS vktx-form_s-8_pos_333-22.htm S-8 POS 189858
2 EX-5.1 vktx-ex5_1.htm EX-5.1 37499
3 GRAPHIC img246856755_0.jpg GRAPHIC 11202
4 GRAPHIC img246856755_1.jpg GRAPHIC 17917
5 GRAPHIC img246856755_2.jpg GRAPHIC 11202
  Complete submission text file 0000950170-24-063590.txt   284369
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

EIN.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-223503 | Film No.: 24974295
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)